A lack of neuroblastoma in Down syndrome: A study from 11 European countries

Cancer Research

Volumn 58, Issue 3, 1998, Pages 448-452

  Satgé, Daniel ^a   Sasco, Annie J ^b   Carlsen, Niels L T ^c   Stiller, Charles A ^d   Rubie, Hervé ^e   Hero, Barbara ^f   De Bernardi, Bruno ^g   De Kraker, Jan ^h   Coze, Carole ⁱ   Kogner, Per ^j   Langmark, Froydis ^k   Hakvoort Cammel, Friederike G A J ^l   Beck, Daniel ^m   Von Der Weid, Nicolas ⁿ   Parkes, Sheila ^o   Hartmann, Olivier ^p   Lippens, Robert J J ^q   Kamps, Willem A ^r   Sommelet, Danièle ^s  

^a CENTRE HOSPITALIER   (France)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

^d Childhood Cancer Research Group   (United Kingdom)

^e CHU PURPAN   (France)

^f Pediatric Hematology Oncology   (Germany)

^g G GASLINI INSTITUTE   (Italy)

^h EMMA CHILDREN S HOSPITAL   (Netherlands)

ⁱ TIMONE HOSPITAL   (France)

^j KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^k CANCER REGISTRY OF NORWAY   (Norway)

^l SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^m LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

ⁿ UNIVERSITY OF BERN   (Switzerland)

^o BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^p INSTITUT GUSTAVE ROUSSY   (France)

^q RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^r UNIVERSITY OF GRONINGEN   (Netherlands)

^s UNIVERSITY HOSPITAL OF NANCY   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN S 100;

ADOLESCENT; ADULT; ARTICLE; CANCER CELL CULTURE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER INHIBITION; CELL DIFFERENTIATION; CHILD; CHILDHOOD CANCER; CHROMOSOME 21; DISEASE ASSOCIATION; DOWN SYNDROME; EUROPE; GENE MAPPING; HUMAN; INFANT; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; NEUROBLASTOMA; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS; TESTIS TUMOR;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 21; COMORBIDITY; DOWN SYNDROME; EUROPE; FEMALE; HUMANS; IMMUNITY, NATURAL; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; NEUROBLASTOMA; S100 PROTEINS;

EID: 17144463566     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Narod, S. A., Hawkins, M. M., Robertson, C. M., and Stiller, C. A. Congenital anomalies and childhood cancer in Great Britain. Am. J. Hum. Genet., 60: 474-485, 1997.
2. Narod, S. A., Stiller, C. A., and Lenoir, G. M. An estimate of the heritable fraction of childhood cancer. Br. J. Cancer, 63: 993-999, 1991.
3. Satgé, D., Sommelet, D., Geneix, A., Malet, P., and Vekemans, M. Tumoral Profile in Down syndrome: a step towards the understanding of the consequences of aneuploidy and the development of cancer. Am. J. Hum. Genet., 55 (Suppl.): A303, 1994.
4. Miller, R. W. Childhood cancer and congenital defects: a study of U. S. death certificates during the period 1960-1966. Pediatr. Res., 3: 389-397, 1969.
5. Foulkes, W. D., Buu, P. N., Filiatrault, D., Leclerc, J-M., and Narod, S. A. Excess of congenital abnormalities in French-Canadian children with neuroblastoma: A case series study from Montréal. Med. Pediat. Oncol., 29: 272-279, 1997.
6. Hosoi, H., Sawada, T., Nakajima, T., Kuroda, H., Saida, T., Sugimoto, T., Tokiwa, K., and Ogita, S. A case of mosaic Down's syndrome concomitant with ganglioneuroma. J. Pediatr. Surg., 24: 210-211, 1989.
7. Stiller, C. A., and Parkin, D. M. International variations in the incidence of neuroblastoma. Int. J. Cancer, 52: 538-543, 1992.
8. Kaatsch, P., Haap, G., and Michaelis, J. Childhood malignancies in Germany: methods and results in nationwide registry. Eur. J. Cancer, 31A: 993-999, 1995.
9. Beckwith, J. B., and Perrin, E. V. In situ neuroblastomas: a contribution to the natural history of neural crest tumors. Am. J.-Pathol., 43: 1089-1104, 1963.
10. Ragab, A. H., Abdel-Mageed, A., Shuster, J. J., Frankel, L. S., Pullen, J., Van Eys, J., Sullivan, M. P., Boyett, J., Borowitz, M., and Crist, W. M. Clinical characteristics and treatment outcome of children with acute lymphoblastic leukemia and Down's syndrome. Cancer (Phila.), 67: 1057-1063, 1991.
11. McWilliams, N. B. Neuroblastoma in infancy, neonatal neuroblastoma and associated conditions. In: C. Pocheldy (ed.), Neuroblastoma: Tumor Biology and Therapy, pp. 230-232. Boca Raton: CRC Press, 1990.
12. Carlsen, N. L. T. Neuroblastomas in Denmark 1943-1980. Acta Paediatr. Suppl., 403: 1-27, 1994.
13. EUROCAT (European Registration of Congenital Anomalies). Down syndrome. In: 15 Years Surveillance of Congenital Anomalies in Europe: 1980-1994, pp. 120-149. Brussels: EUROCAT Working Group, 1997.
14. Mutton, D. E., Alberman, E., Ide, R., and Bobrow, M. Results of first year (1989) of a national register of Down's syndrome in England and Wales. Br. Med. J., 303: 1295-1297, 1991.
15. Baird, P. A., and Sadovnick, A. D. Life tables for Down syndrome. Hum. Genet., 82: 291-292, 1989.
16. Jones, K. L. Neurofibromatosis syndrome. In: Smith's Recognizable Patterns of Human Malformation, pp. 452-453. Philadelphia: W. B. Saunders, 1988.
17. Schneid, H., Vazquez, M. P., Vacher, C., Gourmelen, M., Cabrol, S., and Le Bouc, Y. The Beckwith-Wiedemann syndrome phenotype and the risk of cancer. Med. Pediatr. Oncol., 28: 411-415, 1997.
18. Rescorla, F. J., Morrison, A. M., Engles, D., West, K. W., and Grosfeld, J. L. Hirschsprung's disease: evaluation of mortality and long-term function in 260 cases. Arch. Surg., 127: 934-942, 1992.
19. A Report from the International Clearinghouse for Birth Defects Monitoring Systems: Down's Syndrome. In: Congenital Malformations Worldwide, pp. 157-162. Amsterdam: Elsevier, 1991.
20. Satgé, D., Le Toumeau, A., Verger, J. P., Lefort, S., Geneix, A., Malet, P., Diebold, J., and Vekemans, M. Down syndrome and centroblastic lymphoma. Pathol. Res. Pract., 192: 1266-1269, 1996.
21. Dexeus, F. H., Logothetis, C. J., Chong, C., Sella, A., and Ogden, S. Genetic abnormalities in men with germ cell tumors. J. Urol., 140: 80-84, 1988.
22. Miller, R. W., Fraumeni, J. F., and Hill, J. A. Neuroblastoma: epidemiologic approach to its origin. Am. J. Dis. Child., 115: 253-261, 1968.
23. Neglis, J. P., Smithson, W. A., Gunderson, P., King, F. L., Singher, L. J., and Robison, L. L. Prenatal and perinatal risk factors for neuroblastoma. Cancer (Phila.), 61: 2202-2206, 1988.
24. Sy, W. M., and Edmonson, J. H. The developmental defects associated with neuroblastoma: etiologic implications. Cancer (Phila.), 22. 234-238, 1968.
25. Shanklin, D. R., and Sotelo-Avila, C. In situ tumors in fetuses, newborns and young infants. Biol. Neonat., 14: 286-316, 1969.
26. Feingold, M., Gheradi, G. J., and Simons, C. Familial neuroblastoma and trisomy 13. Am. J. Dis. Child., 121: 451, 1971.
27. Robinson, M. G., and McCorquodale, M. M. Trisomy 18 and neurogenic neoplasia. J. Pediatr., 99: 428-429, 1981.
28. Fryns, J. P., Moerman, P., Kleczkowska, A., and Van den Berghe, H. Neuroblastoma and partial 15q duplication in the fetus. Ann. Genet., 37: 42-43, 1994.
29. Qureshi, F., Jacques, S. M., Johnson, M. P., Reichler, A., and Evans, M. I. Microscopic neuroblastoma in a fetus with a de novo unbalanced translocation 3;10. Am. J. Med. Genet., 53: 24-28, 1994.
30. Power, L. W., and Register, M. K. Down syndrome and acute leukemia: epidemiological and genetic relationships. Lab. Med., 22: 630-636, 1991.
31. Barber, R., and Spiers, P. Oxford survey of childhood cancers: progress report II. Mon. Bull. Minist. Health Lond., 23: 46-52, 1964.
32. Scholl, T., Stein, Z., and Hansen, H. Leukemia and other cancers, anomalies and infections as causes of death in Down's syndrome in the United States during 1976. Dev. Med. Child. Neurol., 24: 817-829, 1982.
33. Satgé, D., Sasco, A. J., Curé, H., Leduc, B., Sommelet, D., and Vekemans, M. J. An excess of testicular germ cell tumors in Down's syndrome: three case reports and a review of the literature. Cancer (Phila.), 80: 929-935, 1997.
34. Carlsen, N. L. T. Neuroblastomas presenting in the first year of life: epidemiological differences from those presenting at older ages. Cancer Detect. Prev., 20: 251-261, 1996.
35. Martinsson, T., Sjöberg, R-M., Hedborg, F., and Kogner, P. Homozygous deletion of the neurofibromatosis-1 gene in the tumor of a patient with neuroblastoma. Cancer Genet. Cytogenet., 95: 183-189, 1997.
36. Miller, R. W. Rarity of neuroblastoma in East Africa. Lancet, 335: 659-660, 1990.
37. Stiller, C. A., and Parkin, D. M. Geographic and ethnic variations in the incidence of childhood cancer. Br. Med. Bull., 52: 682-703, 1996.
38. Brodeur, G. M., and Fong, C. T. Molecular biology and genetics of human neuroblasioma. Cancer Genet. Cylogenet., 41: 153-174, 1989.
39. Mandel, M., Toren, A., Rechavi, G., Dor, J., Ben-Bassat, I., and Neumann, Y. Hormonal treatment in pregnancy: a possible risk factor for neuroblastoma. Med. Pediatr. Oncol., 23: 133-135, 1994.
40. Janerich, D. T., and Bracken, M. B. Epidemiology of trisomy 21: a review and theoretical analysis. J. Chron. Dis., 39: 1079-1093, 1986.
41. Stoll, C., Alembik, Y., Dolt, B., and Feingold, J. No evidence for genomic imprinting in livebom Down syndrome patients. Ann. Genet., 38: 13-18, 1995.
42. Holtzman, D. M., Bayney, R. M., Li, Y., Khosrovi, H., Berger, C. N., Epstein, C. J., and Mobley, W. C. Dysregulation of gene expression in mouse trisomy 16, an animal model of Down syndrome. EMBO J., 11: 619-627, 1992.
43. Epstein, C. J. Specificity versus nonspecificity in the pathogenesis of aneuploid phenotypes. Am. J. Med. Genet., 29, 161-165, 1988.
44. Schwab, M. Is there a neuroblastoma anti-oncogene? In: A. E. Evans, G. J. D'Angio, A. G. Knudson, Jr., and R. Seeger (eds.), Advances in Neuroblastoma Research, Vol. 3. pp. 1-9. New York: Wiley-Liss, 1991.
45. Plantaz, D., Mohapatra, G., Matthay, K. K., Pellarin, M., Seeger, R. C., and Feuerstein, B. G. Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization. Am. J. Pathol., 150: 81-89, 1997.
46. Lastowska, M., Nacheva, E., McGuckin, A., Curtis, A., Grace. C., Pearson, A., and Bown, N. Comparative genomic hybridization study of primary neuroblastoma tumors. Genes Chromosomes Cancer, 18: 162-169, 1997.
47. Brinkschmidt, C., Christiansen, H., Terpe, H. J., Simon, R., Boecker, W., Lampert, F., and Stoerkel, S. Comparative genomic hybridization (CGH) analysis of neuroblastomas: an important methodological approach in paediatric tumour pathology. J. Pathol., 181: 394-400, 1997.
48. Allore, R., O'Hanlon, D., Price, R., Neilson, K., Willard, H. F., Cox, D. R., Marks, A., and Dunn, R. J. Gene encoding the β subunit of S100 protein is on chromosome 21: implications for Down syndrome. Science (Washington DC), 239: 1311-1313, 1988.
49. Satgé. D. A decreased incidence of neuroblastomas in Down syndrome and overproduction of S-100 b protein: an hypothesis. Med. Hypotheses. 46: 393-399, 1996.
50. Donato, R. Perspectives in S-100 protein biology. Cell Calcium, 12: 713-726, 1991.
51. Winningham-Major, F., Staecker, J. L., Barger, S. W., Coats, S., and Van Eldik, L. J. Neurite extension and neuronal survival activities of recombinant S100 β proteins that differ in the content and position of cysteine residues. J. Cell. Biol., 109: 3063-3071, 1989.
52. Kato, K., Suzuki, F., Kurobe, N., Okajima, K., Ogasawara, N., Nagaya, M., and Yamanaka, T. Enhancement of S-100 β protein in blood of patients with Down's syndrome. J. Mol. Neurosci., 2: 109-113, 1990.
53. Griffin, W. S. T., Stanley, L. C., Ling, C., White, L., MacLeod, V., Perrot, L. J., White, C. L., and Araoz, C. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. USA, 86: 7611-7615, 1989.
54. Nagoshi, M., Tsuneyoshi, M., and Enjoji, M. S-100 positive undifferentiated neuroblastomas with a special reference to the tumor stroma related to favorable prognosis. Pathol. Res. Pract., 188: 273-283, 1992.
55. Kligman, D., and Hsieh, L. S. Neurite extension factor induces rapid morphological differentiation of mouse neuroblastoma cells in defined medium. Dev. Brain Res., 33: 296-300, 1987.
56. Selinfreund, R. H., Barger, S. W., Pledger, W. J., and Van Eldik, L. J. Neurotrophic protein S100 β stimulates glial cell proliferation. Proc. Natl. Acad. Sci. USA, 88: 3554-3558, 1991.
57. Fano, G., Mariggio, M. A., Angelella, P., Nicoletti, I., Antonica, A., Fülle, S., and Calissano, P. The S-100 protein causes an increase of intracellular calcium and death of PC12 cells. Neuroscience, 53: 919-925, 1993.
58. Nakazato, Y., and Landing, B. H. Reduced number of neurons in esophageal plexus ganglia in Down syndrome: additional evidence for reduced cell number as a basic feature of the disorder. Pediatr. Pathol., 5: 55-63, 1986.
59. Russel, B. G., Kjaer, I. Tooth agenesis in Down syndrome. Am. J. Med. Genet., 55: 466-471, 1995.
60. Lange, P. Beitrage zur pathologischen Anatomie des Mongolismus. Monatsschr. Kinderheilkde., 5: 233-243, 1906.
61. Gordon, M. B. Morphological changes in the endocrine glands in mongolian idiocy with report of two cases. Endocrinology, 14: 1-6, 1930.
62. Benda, C. E. The adrenals in mongolism. In: The Child with Mongolism, pp. 136-139. New York: Grune & Stratton, Inc., 1960.
63. Mito, T., and Becker, L. E. Developmental changes of S-100 protein and glial flbrillary acidic protein in the brain in Down syndrome. Exp. Neurol., 120: 170-176, 1993.
64. Israel, M. A. Disordered differentiation as a target for novel approaches to the treatment of neuroblastoma. Cancer (Phila.), 71: 3310-3313, 1993.
65. Maroun, L. E. Interferon action and chromosome 21 trisomy (Down syndrome) 15 years later. J. Theor. Biol., 181: 41-46, 1996.